These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
28. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis. Gobbi G; Gaudreau PO; Leblanc N J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186 [TBL] [Abstract][Full Text] [Related]
30. [Bipolar disorders--how to recognize and treat them]. Grunze H; Sasse J; Forsthoff A; Bauer M MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders. Nestsiarovich A; Mazurie AJ; Hurwitz NG; Kerner B; Nelson SJ; Crisanti AS; Tohen M; Krall RL; Perkins DJ; Lambert CG Bipolar Disord; 2018 Dec; 20(8):761-771. PubMed ID: 29920885 [TBL] [Abstract][Full Text] [Related]
32. [Therapeutic evidence for manic episode]. Terao T Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391 [TBL] [Abstract][Full Text] [Related]
34. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Nasrallah HA; Brecher M; Paulsson B Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884 [TBL] [Abstract][Full Text] [Related]
35. International prescribing patterns for mood illness: the International Mood Network (IMN). Mauer S; Alahmari R; Vöhringer PA; Vergne DE; Lövdahl H; Correa E; Patkar A; Pae C; Strejilevich S; Dalley S; Ghaemi SN J Affect Disord; 2014; 167():136-9. PubMed ID: 24955565 [TBL] [Abstract][Full Text] [Related]
36. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study. Bramness JG; Grøholt B; Engeland A; Furu K J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871 [TBL] [Abstract][Full Text] [Related]
37. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. Goldberg JF; Brooks JO; Kurita K; Hoblyn JC; Ghaemi SN; Perlis RH; Miklowitz DJ; Ketter TA; Sachs GS; Thase ME J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents. Dusetzina SB; Weinberger M; Gaynes BN; Farley JF; Sleath B; Hansen RA Pharmacotherapy; 2012 Dec; 32(12):1085-94. PubMed ID: 23208835 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. Wolfsperger M; Greil W; Rössler W; Grohmann R J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907 [TBL] [Abstract][Full Text] [Related]
40. [Methodological approach to inter "guideline" variability in the management of bipolar disorders]. Samalin L; Llorca PM Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]